The medtronic infuse bone graft has garnered attention from the FDA, research organizations, courts and patients. Recently, a study was published on NIH, in which the researcher concluded that “despite the excellent spinal fusion rates promoted by this powerful molecule, the increasingly reported adverse outcomes associated with bone morphogenetic protein […]